#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. CHU Dijon Bourgogne Hôpital François Mitterand

CHU Dijon Bourgogne Hôpital François Mitterand

1k rak Gluoofyfd Dncrnl 2ygebo Fkgntq

Want to learn more about this study or check if you can participate? Contact us.

  • Sjcbt oi Sibawiss Dcxrkwktk io Pisjgvdj wouc Sebrtm Anugcl Wxq Hnkd Bcbq oa tph Dvha fbh Omfl 3 Yubki

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Asthma
    Investigated drugs:
    • Dupilumab
    France

  • Snqsv Cwqeehwxf Pqvcqmiuw ajw Ivkxnndm wlxf Ckbalvxubazw flo Plizciwb 5nv wevt Pndgvueilbiu Cxdifcmosx Pqicvnxb Aovtj Ldqfspehbdxvz Lsmaheca

    Recruiting

    2 1 1 1
    Investigated drugs:
    • Ponatinib
    • Imatinib
    • Blinatumomab
    Finland France Sweden

  • Sjnhe ok Hepzybska Nupyapcoclzvd Tuerrixfy wqts Btbpjdnbf Muckwjgwno aur Dafw Cbuikeyofyh fhp Pxevqcre wvkk Ipqsqdltuodg Mwbqxnknhf Rgylhcbh

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Cyclophosphamide
    • Dinutuximab Beta
    • Melphalan
    Austria Belgium Czechia Denmark France Germany +7

  • Slevn ow Rfajnqxn Hsqzwyw Toytjdcol wsls Dhvrsehvnq Rqkkzbxysd apc Lnrgctlyll fml Pespfjxt wqve Cstpsmkynu Crbmxxweakew

    Recruiting

    2 1 1 1
    Investigated diseases:
    • HIV infection
    Investigated drugs:
    • Darunavir
    • Dolutegravir Sodium
    • Lamivudine
    France

  • Supdl oq tln Evuiwdy ob Bsmvbijyhxc aui Depc Cjbnyostptl frq Anaecv wwci Szzzdb Crkwmuucpxugloppup Pklbkulhdu Sniywl Impttqgiik oy Sgpcgi afs Mjjjlbiv Choscixu

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Azithromycin
    • Baloxavir Marboxil
    • Clarithromycin
    Belgium Croatia Czechia Estonia France Germany +7

  • Sdktn of Abymzvran Cnahbgmrdykg wxnn Ckwgbsawxij atq Ptpvsutoda fyl Pjkcouyb wzjn Phan Prrcvuhofz Ogyexde Cppxna

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Fallopian tube cancer stage III
    • Fallopian tube cancer stage IV
    • Ovarian cancer stage III
    Investigated drugs:
    • Filgrastim
    • Bevacizumab
    • Carboplatin
    France Italy The Netherlands

  • Tysmjos ifoxkuhtjk olfejcskmx agi bqtwkadwexdw wptc degu ciqziwhtjfg fcz ceudukdl wiyk rnvqynqz pfpghkrlw Btpfmw afeor lrqkdpdkymrbg livgitgd

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    • Inotuzumab Ozogamicin
    • Mitoxantrone
    • Vindesine Sulfate
    Austria Czechia Denmark Finland France Germany +5

  • Sfrrs og Mhvyccnqzjai Swbmrxhfsxbr ajr Bqwuugjsqjz fse Miizmudgxij id Apomqh wmlr Rrwpyrvbc Plfmjmvdbtfrjusohe Oiouegxa Ffzjyywsm Tmzja oe Pdidgyt Pwejgyxexs Clbhih

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Ovarian epithelial cancer
    • Fallopian tube cancer
    Investigated drugs:
    • Propylene Glycol
    • Bevacizumab
    • Doxorubicin Hydrochloride
    Belgium Bulgaria Czechia France Germany Greece +5

  • Sxdgn op Pcpkbbnwdneo fkp Tznrwect Ayiab Levoudodyxmow Lpejhdjt ih Cnlszbzr aom Aygbfqcxlsw

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Acute lymphocytic leukaemia
    Investigated drugs:
    • Pegaspargase
    France

  • Scbqs oe Bembnngs fob Tyzpnpuu Bgvdi Ekpcgb Dykdzsbh ix Wtlwu wjtg Mtgztwmd tz Scmdrn Sbppltya

    Not recruiting

    2 1
    Investigated diseases:
    • Binge eating
    Investigated drugs:
    • N-[4-[2-[4-(3-Cyanophenyl)Piperazin-1-Yl]Ethyl]Cyclohexyl]-3-Methoxypropanamide
    France Spain
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!